MissionIR Articles
-
MissionIRNewsBreaks – SRAX (NASDAQ: SRAX) Slated to Host, Present at B. Riley Securities 2021 Vision Day
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, will be both hosting and presenting at the upcoming B. Riley Securities 2021 Vision Day via its Sequire Virtual…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Appoints Diabetes, Behavioral Health Experts to Scientific Advisory Board
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced the appointment of two renowned experts to its Scientific Advisory Board (“SAB”). Dr. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical…
-
MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $3.074M in Registered Direct Offering
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously disclosed registered direct offering of 3,650,840 shares of its…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Appears on C3 Chat Show Podcast
CNS Pharmaceuticals (NASDAQ: CNSP) chairman and CEO John Climaco was featured on a recent C3 Chat Show Podcast. The podcast, hosted by Sid Vaidya and Eric Gershey, explores topics related to entrepreneurship, life experiences and…
-
MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Secures $5.1M in Underwritten Public Offering
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial metal 3D printing industry, has announced the closing of its previously disclosed underwritten public offering of 1,488,507 shares of common stock,…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX), First Wave, Receive Notice of Allowance for Niclosamide Patent
AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, announced that it, along with First Wave Bio Inc., has received a notice of allowance from…
-
MissionIRNewsBreaks – Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Enters LOI with Leading European Digital Wallet and Mobile Marketing Company
Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced its entry into…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) Announces API Synthesis of Multiple Tryptamine Derivatives
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc., a wholly-controlled subsidiary of Cybin, has achieved the earn-out milestones for the period commencing Nov.…
-
MissionIRNewsBreaks – Knightscope Inc. Expresses Gratitude to Investors
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that that it has over 18,000 investors! In the update, the company expressed its gratitude to its investors for…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at H.C. Wainwright BIOCONNECT 2021
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will present at the H.C. Wainwright…
-
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Announces Strategic Appointments of Chiefs Kathleen O’Toole and Sylvia Moir
Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced the appointment of Kathleen O’Toole, retired commissioner of Boston and Seattle Police Departments, and Sylvia Moir, retired chief of Tempe Police Department, to…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Strategic Partnership with Kernel
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, is excited to announce that it has entered into an agreement with neurotech pioneer HI, LLC dba Kernel (“Kernel”) to leverage its innovative…
-
MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $3M Registered Direct Offering
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional and accredited investors for…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Issues Letter to Shareholders
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today issued a letter to its shareholders and the investment community from its CEO and President James Sapirstein.…
-
MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Announces Pricing of $4.5M Public Offering
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial metal 3D printing industry, has announced the pricing of an underwritten public offering of 1,488,507 shares of common stock at a…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Biotech Showcase Digital 2021 Conference
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, will be participating in the upcoming Biotech Showcase Digital 2021 conference. The multiday event is scheduled for Jan. 11–15, 2021. As part…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at the H.C. Wainwright BioConnect 2021 Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its CEO, John Climaco, will present…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) Releases Report on Patent Filings, Therapeutics Program Development
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, has provided an update on its patent filings. The company has eight filings, all tied to Cybin’s novel therapeutics, delivery mechanisms and treatment…
-
MissionIRNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics Completes QM CoRE(TM) Integration
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its wholly owned subsidiary Helomics has completed the integration of Quantitative Medicine’s (“QM”)…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Is Pushing the Boundaries of Performance in Growing Market
- Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlighted in Italian Press for Juve Stabia Player Development, Market Value Surge
- Newton Golf Company Inc. (NASDAQ: NWTG) Drives Momentum amid Record Growth in Golf Trials
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Partners With Media Exceed to Bring Neural Wearables to Japan